TECON BIOLOGY Co.LTD
Shenzhen Stock ExchangeTotal Valuation
TECON BIOLOGY Co.LTD carries a market capitalization of 9.22B, placing it among publicly traded companies globally. Its enterprise value stands at 14.84B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 9.22B |
| Enterprise Value | 14.84B |
Share Statistics
TECON BIOLOGY Co.LTD currently has 1.37B shares outstanding.
| Shares Outstanding | 1.37B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
TECON BIOLOGY Co.LTD trades at a trailing price-to-earnings ratio of 27.78. The price-to-sales ratio is 0.83, and the price-to-book ratio stands at 4.31.
| PE Ratio | 27.78 |
| PS Ratio | 0.83 |
| PB Ratio | 4.31 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | 35.56 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, TECON BIOLOGY Co.LTD trades at an EV/EBITDA multiple of 104.02 and an EV/FCF ratio of 32.47. The EV/Sales ratio of 1.24 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 104.02 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.24 |
| EV / EBITDA | 104.02 |
| EV / EBIT | 104.02 |
| EV / FCF | 32.47 |
Financial Position
TECON BIOLOGY Co.LTD maintains a current ratio of 1.63, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 78.32, indicating elevated leverage, while an interest coverage ratio of 1.08 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.63 |
| Quick Ratio | 0.49 |
| Debt / Equity | 78.32 |
| Debt / EBITDA | 46.33 |
| Interest Coverage | 1.08 |
Financial Efficiency
| Return on Equity (ROE) | -6.97 |
| Return on Assets (ROA) | -0.97 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 7.12 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.16 |
Taxes
Over the trailing twelve months, TECON BIOLOGY Co.LTD has paid 36.37M in income taxes, reflecting an effective tax rate of 4.14.
| Income Tax | 36.37M |
| Effective Tax Rate | 4.14 |
Stock Price Statistics
TECON BIOLOGY Co.LTD's stock has gained approximately 7.6555% over the past 52 weeks. The 50-day moving average sits at 6.88, while the 200-day moving average is 7.24.
| Beta (5Y) | N/A |
| 52-Week Price Change | 7.6555% |
| 50-Day Moving Average | 6.88 |
| 200-Day Moving Average | 7.24 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, TECON BIOLOGY Co.LTD generated 11.95B in revenue and converted that into -174.25M in net income, yielding earnings per share of -0.10. EBITDA reached 142.69M, while operating income came in at 142.69M.
| Revenue | 11.95B |
| Gross Profit | 918.94M |
| Operating Income | 142.69M |
| Pretax Income | -102.52M |
| Net Income | -174.25M |
| EBITDA | 142.69M |
| EBIT | 142.69M |
| Earnings Per Share (EPS) | -0.10 |
Balance Sheet
TECON BIOLOGY Co.LTD holds 3.26B in cash and equivalents against 6.61B in total debt, resulting in a net debt position of 2.58B. Total book value stands at 2.30B, with working capital of 4.19B providing operational flexibility.
| Cash & Cash Equivalents | 3.26B |
| Total Debt | 6.61B |
| Net Debt | 2.58B |
| Equity (Book Value) | 2.30B |
| Book Value Per Share | 1.69 |
| Working Capital | 4.19B |
Cash Flow
After subtracting -278.54M in capital expenditures, free cash flow totaled -278.54M - equivalent to -0.20 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -278.54M |
| Free Cash Flow | -278.54M |
| FCF Per Share | -0.20 |
Margins
TECON BIOLOGY Co.LTD operates with a gross margin of 7.69, reflecting its pricing power and cost economics. The operating margin of 1.19 and net profit margin of -1.46 provide insight into operational efficiency.
| Gross Margin | 7.69 |
| Operating Margin | 1.19 |
| Pretax Margin | -0.86 |
| Profit Margin | -1.46 |
| EBITDA Margin | 1.19 |
Dividends & Yields
The company's payout ratio of -314.14 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.24 |
| Dividend Yield | N/A |
| Payout Ratio | -314.14 |
| Shareholder Yield | 8.55 |
| FCF Yield | 2.81 |
Stock Splits
TECON BIOLOGY Co.LTD's most recent stock split took place on May 20, 2015 with a 1:2 split ratio.
| Last Split Date | 5/20/2015 |
| Split Ratio | 1:2 |
Scores
TECON BIOLOGY Co.LTD posts an Altman Z-Score of 1.69, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.69 |